NCT01002898View on ClinicalTrials.gov

Ritonavir-boosted Lopinavir Monotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
HIV
Interventions
DRUG

lopinavir/ritonavir soft gel capsule

Ritonavir-boosted lopinavir in soft gel formulation at 400/100 mg and lamivudine at 150 mg were given twice daily.

Trial Locations (1)

11000

Bamrasnaradura Infectious Diseases Institute, Nonthaburi

All Listed Sponsors
lead

Bamrasnaradura Infectious Diseases Institute

OTHER_GOV

NCT01002898 - Ritonavir-boosted Lopinavir Monotherapy | Biotech Hunter | Biotech Hunter